6533b81ffe1ef96bd1277959
RESEARCH PRODUCT
Regorafenib dose escalations in the prospective, observational CORRELATE study in patients with metastatic colorectal cancer
Emmanuelle DochyJ. O’connorSabine Fiala-buskiesAndrés CervantesMichel DucreuxAlfredo Falconesubject
Oncologymedicine.medical_specialtyColorectal cancerbusiness.industryHematologymedicine.diseasechemistry.chemical_compoundOncologychemistryInternal medicineRegorafenibmedicineIn patientObservational studybusinessyear | journal | country | edition | language |
---|---|---|---|---|
2019-07-01 | Annals of Oncology |